Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marija Balic

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
The Journal of Molecular Diagnostics : JMD|February 14, 2009
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumorsMartin Pichler, Marija Balic, Elke Stadelmeyer, et al.
Journal of the National Cancer Institute|August 11, 2024
Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trialsJulia Foldi, Neil Carleton, Stewart J Anderson, et al.
Oncology Reports|January 12, 2005
Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancerThomas Bauernhofer, Sabine Zenahlik, Günter Hofmann, et al.
Breast Care (Basel, Switzerland)|January 27, 2022
Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer PatientsChristoph Suppan, Daniel Steiner, Eva Valentina Klocker, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 3, 2026
A novel algae oil-based emulsion enhances chemotherapy outcome in human cancer modelsBirgit Steiner-Zitzenbacher, Christina Karner, Andreas Uellen, et al.
Clinical Chemistry and Laboratory Medicine|March 24, 2007
Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancerChristoph Ausch, Nadia Dandachi, Veronika Buxhofer-Ausch, et al.
Wiener Klinische Wochenschrift|January 28, 2022
Updated Austrian treatment algorithm in HER2+ metastatic breast cancerRupert Bartsch, Simon Peter Gampenrieder, Gabriel Rinnerthaler, et al.
BMC Cancer|July 26, 2013
Genetic and epigenetic analysis of putative breast cancer stem cell modelsMarija Balic, Daniela Schwarzenbacher, Stefanie Stanzer, et al.
BMC Cancer|December 31, 2015
Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapyChristoph Suppan, Vesna Bjelic-Radisic, Marlen La Garde, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 24, 2010
Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cellsMarija Balic, Nadine Rapp, Stefanie Stanzer, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Molecular Diagnostics : JMD|February 14, 2009
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumorsMartin Pichler, Marija Balic, Elke Stadelmeyer, et al.
Journal of the National Cancer Institute|August 11, 2024
Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trialsJulia Foldi, Neil Carleton, Stewart J Anderson, et al.
Oncology Reports|January 12, 2005
Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancerThomas Bauernhofer, Sabine Zenahlik, Günter Hofmann, et al.
Breast Care (Basel, Switzerland)|January 27, 2022
Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer PatientsChristoph Suppan, Daniel Steiner, Eva Valentina Klocker, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 3, 2026
A novel algae oil-based emulsion enhances chemotherapy outcome in human cancer modelsBirgit Steiner-Zitzenbacher, Christina Karner, Andreas Uellen, et al.
Clinical Chemistry and Laboratory Medicine|March 24, 2007
Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancerChristoph Ausch, Nadia Dandachi, Veronika Buxhofer-Ausch, et al.
Wiener Klinische Wochenschrift|January 28, 2022
Updated Austrian treatment algorithm in HER2+ metastatic breast cancerRupert Bartsch, Simon Peter Gampenrieder, Gabriel Rinnerthaler, et al.
BMC Cancer|July 26, 2013
Genetic and epigenetic analysis of putative breast cancer stem cell modelsMarija Balic, Daniela Schwarzenbacher, Stefanie Stanzer, et al.
BMC Cancer|December 31, 2015
Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapyChristoph Suppan, Vesna Bjelic-Radisic, Marlen La Garde, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 24, 2010
Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cellsMarija Balic, Nadine Rapp, Stefanie Stanzer, et al.
Pageof 13